Radiation for limited cancer spread in advanced breast cancer
Part of Cancer, Skin clinical trials.
This trial tests whether targeted radiation can control a few growing spots of breast cancer while the rest of the cancer stays stable on your current treatment. It aims to delay the need to switch to a new therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced breast cancer that has started to grow in a limited number of spots (5 or fewer outside the brain) while on your first treatment for metastatic disease.
- Your current treatment has kept the cancer under control for at least 6 months before these new spots appeared.
- Your cancer type is either hormone receptor positive and HER2 negative, or HER2 positive, and you are on the matching first-line therapy.
- You have not had to change your treatment yet because of this new growth.
- You have had a CT or bone scan within the last 45 days.
- The growing spots are in the liver or lungs, but not more than 3 sites in either organ, and they are not in the brain or causing spinal cord compression.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of radiation for people whose cancer has spread to a few new spots while on or after treatment. It tests whether a precise, high-dose radiation approach (stereotactic) works better than the usual palliative radiation for controlling these growing spots.
This trial tests whether treating each spot of cancer that has spread (but only a few spots) with focused radiation can help control breast cancer. It aims to see if this approach can stop the cancer from growing further without needing strong whole-body treatments right away.
This trial tests whether treating just the few spots where breast cancer has spread (called oligometastases) with radiation or surgery can help control the disease. It is for people whose cancer has spread to 3 or fewer places, each small in size, and who are healthy enough for local treatments.
This Phase 2 study tests whether adding a very focused type of radiation to standard drug treatment can better control metastatic breast cancer. It is for people whose cancer is only progressing in one spot, seen on a PET scan.
This trial looks at adding a focused radiation treatment called SBRT to standard care for cancers that have spread to a limited number of spots. It aims to control those spread-out tumors while still using the usual cancer treatment plan.
This trial tests a precise, high-dose radiation treatment (SABR) for people whose cancer has spread to a few spots (up to 5) and is not growing in the brain or been previously treated with radiation in those same spots.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.